/
HBPCF
$1.71-$0.02 (-1.16%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.71 – $1.73
0% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change+$0.68
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $167.0K | $56.0K | $212.0K | $173.0K | $12.0K | $13.0K | $10.1K | $9.9K |
| Gross profit | −$167.0K | −$56.0K | −$212.0K | −$173.0K | −$12.0K | −$13.0K | −$10.1K | −$7.2K |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $6.1M | $5.0M | $5.9M | $5.9M | $4.5M | $5.3M | $6.1K | $3.6M |
| Operating income | −$8.5M | −$7.5M | −$8.6M | −$9.6M | −$6.5M | −$6.3M | −$9.4K | −$5.0M |
| EBITDA | −$8.4M | −$6.7M | −$8.4M | −$9.1M | −$6.5M | −$6.3M | −$9.2K | −$5.0M |
| Net income | −$8.6M | −$7.5M | −$9.0M | −$8.0M | −$6.6M | −$6.3M | −$9.3K | −$5.0M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.09 | -0.07 | -0.07 | -0.06 | -0.04 | -0.03 | -0.00 | -0.07 |
Annual figures · source: Financial Modeling Prep
Peer comparison
HELIX BIOPHARMA CORP
HELIX BIOPHARMA CORP
Held by traders on TradeandTell
No one on the platform currently holds HBPCF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HBPCF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-08-16 | 1-for-5reverse |
Recent trades on TradeandTell
No one on the platform has traded HBPCF yet.